Public Health Emergency - Leading a Nation Prepared
She serves as the Section Editor for the Journal of Antibiotics, was a member of the Product Development working group for Biodefense for the NIAID, and was an Advisory Board Member of Optimer Pharmaceuticals, Inc. as well as the Supervisory Board of GPC Biotech. At Optimer, she was involved with the development of fidaxomicin. She is currently on the Supervisory Board of Curetis a European based, publicly traded, molecular diagnostic company. In 2018 she was appointed as a Scientific Advisor to GARDP (Global Antibiotic Research and Development Partnership, a DNDi/WHO initiative). She serves as a consultant and scientific advisor to a few other biotechnology companies. She has authored over 250 publications and several reviews, book chapters and served as an editor for books.
For further questions or comments on the National Biodefense Science Board, please contact us via the
National Biodefense Science Board Contact Form.
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages